Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China · Delayed Price · Currency is CNY 8.57
-0.02 (-0.23%)
Aug 14, 2026, 3:00 PM CST
SHA:600867 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,043 | 2,947 | 2,010 | 3,075 | 2,778 | 3,268 |
Revenue Growth | 47.04% | 46.66% | -34.66% | 10.69% | -14.98% | 12.99% |
Gross Profit Gross Profit Growth | 2,145 | 2,061 | 1,462 | 2,454 | 2,150 | 2,681 |
Operating Income Operating Income Growth | 648.66 | 582.23 | 114.5 | 1,270 | 882.29 | 1,246 |
Net Income Net Income Growth | 1,237 | 1,219 | -41.95 | 1,168 | 1,582 | 1,308 |
Earnings Per Share EPS Growth | 0.61 | 0.62 | -0.02 | 0.59 | 0.79 | 0.64 |
EPS Growth | - | - | - | -25.32% | 23.44% | 39.13% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 2,903 |
Real Estate Industry Real Estate Industry Growth | 7.34 |
Total Total Growth | 2,911 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,805 | 1,497 | 645.6 | 1,160 | 846.52 | 902.04 |
Total Debt Total Debt Growth | 683.56 | 525.89 | 694.15 | 150 | 2.65 | 2.65 |
Net Cash (Debt) Net Cash Growth | 1,122 | 971.17 | -48.55 | 1,010 | 843.87 | 899.39 |
Net Cash Growth | - | - | - | 19.65% | -6.17% | 21.36% |
Net Cash Per Share Net Cash Per Share Growth | 0.55 | 0.49 | -0.02 | 0.51 | 0.42 | 0.44 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 853.07 | 689.23 | 462.33 | 861.52 | 863.09 | 1,180 |
Capital Expenditures CapEx Growth | -530.46 | -517.69 | -568.73 | -348.13 | -492.88 | -600.75 |
Free Cash Flow Free Cash Flow Growth | 322.61 | 171.53 | -106.4 | 513.4 | 370.21 | 579.62 |
Free Cash Flow Growth | - | - | - | 38.68% | -36.13% | -18.67% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 70.48% | 69.93% | 72.76% | 79.81% | 77.39% | 82.04% |
Operating Margin | 21.31% | 19.75% | 5.70% | 41.31% | 31.75% | 38.12% |
Pretax Margin | 50.25% | 50.12% | -7.08% | 44.41% | 65.85% | 46.96% |
Profit Margin | 40.63% | 41.36% | -2.09% | 37.97% | 56.93% | 40.03% |
FCF Margin | 10.60% | 5.82% | -5.29% | 16.69% | 13.32% | 17.74% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.300 | 0.250 | 0.250 | 0.500 | 0.300 |
Dividend Per Share Growth | 20.00% | 20.00% | 0% | -50.00% | 66.67% | 42.86% |
Dividend Yield | 3.50% | 3.81% | 3.33% | 2.54% | 6.13% | 3.26% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.13 | 13.03 | - | 18.40 | 11.51 | 16.94 |
Forward PE | 25.97 | 31.42 | 42.42 | 20.43 | 16.39 | 23.83 |
P/FCF Ratio | 51.96 | 92.57 | - | 41.84 | 49.19 | 38.23 |
PS Ratio | 5.51 | 5.39 | 7.82 | 6.99 | 6.55 | 6.78 |